Others studies have analyzed newly diagnosed cases of CML and found differential activation of Sonic Hh (SHH) signaling was seen in 50% of chronic phase, 70% of accelerated phase and over 80% of blast crisis cases. This evidence concerns the gene SHH and chronic myelogenous leukemia, BCR-ABL1 positive.